Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,383,042
+$1,158,539 QoQ
Shares Held
4,488
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1,660
of 4,605 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names. LLY ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,720 | $7,294,018 | |
| 2 | ABBV |
AbbVie Inc.
|
22,305 | $5,612,830 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
4,488 | $5,383,042 | |
| 4 | AMGN |
Amgen Inc
|
14,633 | $5,298,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,306 | $4,022,821 | |
| 6 | PFE |
Pfizer Inc
|
15,983 | $384,870 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,755 | $348,066 | |
| 8 | AZN |
Astrazeneca PLC
|
1,713 | $324,819 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,383,042 | 4,488 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,224,503 | 4,593 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,306,243 | 4,007 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,545,484 | 7,268 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,955,627 | 26,988 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,386,231 | 4,100 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,803,904 | 3,632 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,027,256 | 3,417 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,045,698 | 3,364 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,308,985 | 2,968 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,174,000 | 2,014 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,083,928 | 2,018 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,202,330 | 4,696 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,084,863 | 3,159 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $443,763 | 1,213 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $375,086 | 1,160 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $396,857 | 1,224 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $312,716 | 1,092 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $304,394 | 1,102 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $254,617 | 1,102 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $298,835 | 1,302 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $246,415 | 1,319 | Shares | Sole | 2021-04-27 | |
| No filing history on record for this holder in this stock. | ||||||